Efficacy and Safety Analysis of Anlotinib in the Posterior Line Treatment of Advanced Lung Cancer

Efficacy and Safety Analysis of Anlotinib in the Posterior Line Treatment of Advanced Lung Cancer

SUN Xuan

PDF(1271 KB)

PDF(1271 KB)

Chinese And Foreign Medical Research ›› 2025, Vol. 23 ›› Issue (7) : 101-104. DOI: 10.14033/j.cnki.cfmr.2025.07.027

Experience

Efficacy and Safety Analysis of Anlotinib in the Posterior Line Treatment of Advanced Lung Cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 23(7): 101-104 https://doi.org/10.14033/j.cnki.cfmr.2025.07.027

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1271 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉